News

Charles River Laboratories International, Inc. announced that it has completed the previously announced acquisition of Vigene Biosciences, Inc. for $292.5 million in cash, subject to customary closing adjustments. In addition to the initial purchase price, the transaction includes additional...

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening diseases and public health threats, announced an advance purchase agreement (APA) with Gavi, the Vaccine Alliance, to provide...

Brussels Airport continues to invest in its logistics zone Brucargo, where it took delivery of a new building accommodating 4,000m² of warehousing and office space. The building will become the home base of Medexi, a joint venture by several...

RedHill Biopharma has reported initial findings from a preclinical study, which revealed that its drug candidate, opaganib (Yeliva, ABC294640), could block Covid-19 variants of concern. Opaganib is an investigational host-targeted oral drug being developed to treat Covid-19. With antiviral and...

Lonza announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over CHF 20 million, will allow Lonza to provide a smoother transition from small-scale to large-scale manufacturing...

Held on 11 June, ASPA and Messe Frankfurt India united senior leaders and industry experts for a panel discussion on “Protecting the lives and pharmaceutical supply chain during COVID-19” at The Authentication Forum webinar. Setting up an authentication &...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and...